Evidence map›Paper›PMID 28698627›Full record

ArticleScientific reports2017

The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells.

Camille Loubiere, Stephan Clavel, Jerome Gilleron, Rania Harisseh, Jeremy Fauconnier, Issam Ben-Sahra, Lisa Kaminski, Kathiane Laurent, Stephanie Herkenne, Sandra Lacas-Gervais and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Mitochondrial CaJournal of cellular physiology · 2025
    Review
  11. Dysregulation of Mitochondrial Function in Cancer Cells.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Camille LoubiereInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Stephan ClavelInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Jerome GilleronInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Rania HarissehInserm U1060/ INRA 1235/ Université-Lyon1/ INSA, Lyon, France.
Jeremy FauconnierInserm U1046, UMR CNRS 9214, Université de Montpellier, Montpellier, France.
Issam Ben-SahraNorthwestern University, Chicago, IL, USA.
Lisa KaminskiInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Kathiane LaurentInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Stephanie HerkenneDepartment of Biology, University of Padua, Padua, Italy.
Sandra Lacas-GervaisCentre Commun de Microscopie Appliquée, Université de Nice Sophia-Antipolis, Nice, France.
Damien AmbrosettiCentre Hospitalier Universitaire (CHU) de Nice, Hôpital Pasteur, Laboratoire Central d'Anatomo Pathologie, 06002, Nice, France.
Damien AlcorInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Stephane RocchiUniversité Nice Côte d'Azur, Inserm, Nice, France.
Mireille CormontInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.
Jean-François MichielsCentre Hospitalier Universitaire (CHU) de Nice, Hôpital Pasteur, Laboratoire Central d'Anatomo Pathologie, 06002, Nice, France.
Bernard MariCNRS, Institute of Molecular and Cellular Pharmacology, Sophia Antipolis, France.ORCID 0000-0002-0422-9182
Nathalie M MazureInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-Inserm U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France.
Luca ScorranoDepartment of Biology, University of Padua, Padua, Italy.ORCID 0000-0002-8515-8928
Alain LacampagneInserm U1046, UMR CNRS 9214, Université de Montpellier, Montpellier, France.
Abdallah GharibInserm U1060/ INRA 1235/ Université-Lyon1/ INSA, Lyon, France.
Jean-François TantiInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France.ORCID 0000-0003-1782-1318
Frederic BostInserm U1065, C3M, Team Cellular and Molecular Physiopathology of Obesity and Diabetes, Nice, France. bost@unice.fr.
Inserm · FRCentre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Nice · FRUniversité Claude Bernard Lyon 1 · FRUniversity of Padua · ITNorthwestern University · USUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial integrity is critical for the regulation of cellular energy and apoptosis. Metformin is an energy disruptor targeting complex I of the respiratory chain. We demonstrate that metformin induces endoplasmic reticulum (ER) stress, calcium release from the ER and subsequent uptake of calcium into the mitochondria, thus leading to mitochondrial swelling. Metformin triggers the disorganization of the cristae and inner mitochondrial membrane in several cancer cells and tumors. Mechanistically, these alterations were found to be due to calcium entry into the mitochondria, because the swelling induced by metformin was reversed by the inhibition of mitochondrial calcium uniporter (MCU). We also demonstrated that metformin inhibits the opening of mPTP and induces mitochondrial biogenesis. Altogether, the inhibition of mPTP and the increase in mitochondrial biogenesis may account for the poor pro-apoptotic effect of metformin in cancer cells.

Indexed as

AnimalsCalciumCell Line, TumorEndoplasmic ReticulumEndoplasmic Reticulum StressEnergy MetabolismHumansMetforminMiceMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial SwellingModels, BiologicalOrganelle BiogenesisCalciumMetforminMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition Pore

Identifiers

PMID28698627
PMCPMC5506014
OpenAlexW2728232665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.